Central Nucleus Amygdala Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Central Nucleus of the Amygdala (CeA) is a critical杏仁核输出结构，位于杏仁核复合体的中央部位。作为大脑恐惧、焦虑和自主神经控制的核心调节中枢，CeA协调对威胁的生理和行为反应，并与多种神经退行性疾病的发生发展密切相关。
| Property |
Value |
| Category |
Cell Types |
| Brain Region |
Amygdala, Central Nucleus |
| Neuron Type |
GABAergic Projection Neurons |
| Primary Neurotransmitter |
GABA |
| Species |
Human, Mouse, Rat |
¶ Anatomy and Precise Location
The Central Nucleus of the Amygdala is located in the medial portion of the amygdala complex, approximately 2.5-3.0 mm lateral to the midline and 8-9 mm ventral to the cortical surface in adult humans. In rodents, the CeA lies approximately 2.0-2.5 mm caudal to the bregma.
The CeA is divided into three anatomically and functionally distinct divisions:
- Central Division (CeC): The primary output zone, containing mostly GABAergic projection neurons
- Lateral Division (CeL): The main input-receiving region, subdivided into lateral (CeLL) and medial (CeLM) caps
- Medial Division (CeM): Visceromotor output region with strong hypothalamic connections
- Medial: Optic tract and tuberal hypothalamus
- Lateral: Basolateral amygdala (BLA)
- Dorsal: Stria terminalis and caudate nucleus
- Ventral: Entorhinal cortex and presubiculum
¶ Morphology and Cellular Characteristics
The CeA contains primarily GABAergic neurons that project to downstream targets:
- Protein kinase C delta (PKCδ)-positive neurons: Fear conditioning circuits
- Somatostatin (SST)-positive neurons: Stress and anxiety modulation
- Corticotropin-releasing hormone (CRH)-positive neurons: HPA axis activation
- Proenkephalin (PENK)-positive neurons: Pain modulation
| Marker |
Function |
Disease Relevance |
| CRH |
Stress response |
Depression, anxiety |
| SST |
Inhibitory modulation |
Alzheimer's |
| PKCδ |
Fear conditioning |
Anxiety disorders |
| NPY |
Anxiety reduction |
Epilepsy, depression |
| PENK |
Pain modulation |
Parkinson's |
- Soma size: Medium (15-25 μm diameter)
- Dendritic architecture: Spiny dendrites, moderate branching
- Axonal projections: Extensive to hypothalamus and brainstem
- Electrophysiology: Regular-spiking, some burst-firing
- GABA synthesis: GAD67 (GAD1) and GAD65 (GAD2)
- GABA-A receptors: Fast inhibitory transmission
- GABA-B receptors: Modulatory effects
- Vesicular GABA transporter (VGAT)
Corticotropin-Releasing Hormone (CRH)
- Released during stress
- Activates HPA axis
- Modulates anxiety and fear
- CRH receptor 1 (CRHR1) and CRHR2
Somatostatin (SST)
- Inhibits growth hormone release
- Modulates neuronal excitability
- Anti-anxiety effects
- SSTR1-SSTR5 receptors
Neuropeptide Y (NPY)
- Anxiolytic properties
- Reduces food intake
- Anti-epileptic effects
- Y1-Y5 receptors
- CRH → CRHR1 → cAMP/PKA: Anxiety behavior
- p38 MAPK: Stress-induced plasticity
- JNK: Neuronal apoptosis
- ERK/MAPK: Long-term fear memory
- mTOR: Synaptic protein synthesis
- BDNF: Neuronal survival
| Source |
Signal Type |
Function |
| Basolateral Amygdala |
Glutamatergic |
Emotional valence |
| Parabrachial Nucleus |
Glutamatergic |
Visceral sensory |
| Hypothalamus |
GABAergic/Peptidergic |
Homeostatic signals |
| Thalamus ( medial ) |
Glutamatergic |
Sensory relay |
| Prefrontal Cortex |
Glutamatergic |
Cognitive control |
| Hippocampus |
Glutamatergic |
Contextual memory |
| Brainstem nuclei |
Mixed |
Autonomic input |
| Target |
Signal Type |
Function |
| Paraventricular Hypothalamus |
CRH, GABA |
HPA axis activation |
| Lateral Hypothalamus |
GABA |
Autonomic control |
| Periaqueductal Gray |
GABA |
Pain modulation |
| Nucleus Tractus Solitarius |
GABA |
Visceral control |
| Ventral Tegmental Area |
GABA |
Reward modulation |
| Locus Coeruleus |
CRH |
Arousal modulation |
¶ Fear and Anxiety
The CeA is essential for acquiring and expressing fear responses:
- Acquisition: Associations between neutral and aversive stimuli
- Expression: Freezing behavior and autonomic responses
- Extinction: Learning that stimuli are safe
- Generalization: Fear responses to similar stimuli
- Threat detection: Rapid processing of potential danger
- Risk assessment: Evaluation of environmental safety
- Stress response: Coordination of behavioral and physiological reactions
- Anxiety disorders: Dysregulated CeA activity
- Heart rate modulation via vagus
- Blood pressure regulation
- Baroreceptor reflex integration
- Breathing rate modulation
- Stress-induced hyperventilation
- Panic responses
- Gastric motility regulation
- Stress-induced gastric ulceration
- Appetite suppression
- Activation of endogenous opioid systems
- Descending inhibition pathways
- Interaction with PAG
- Enhanced pain sensitivity in stress
- Chronic pain states
- Headaches and migraines
¶ Reward and Motivation
- Stress-induced anorexia
- Leptin and ghrelin interaction
- NPY modulation of appetite
- Drug reward processing
- Withdrawal symptoms
- Relapse mechanisms
¶ Behavioral and Psychological Symptoms
- Anxiety: Present in 40-50% of AD patients
- Agitation: CeA dysfunction contributes
- Depression: Comorbid depression common
- Cardiovascular dysregulation: Orthostatic hypotension
- Sleep disturbances: Altered circadian rhythms
- GI dysfunction: Constipation, dysphagia
- Amyloid deposition: In CeA neurons
- Tau pathology: Neurofibrillary tangles
- Cholinergic loss: Reduced acetylcholine
- CRH dysregulation: HPA axis hyperactivity
- Anxiety: 30-50% prevalence
- Depression: Up to 50% of patients
- Autonomic dysfunction: Orthostatic hypotension
¶ Lewy Body Pathology
- α-Synuclein: Deposited in CeA
- Neuronal loss: Dopaminergic denervation
- Circuit dysfunction: Basal ganglia-amygdala circuits
- Anxiety: 20-30% prevalence
- Depression: Emotional lability
- Pseudobulbar affect: CeA involvement
- Respiratory dysfunction: Leading cause of death
- Cardiovascular instability: Orthostatic hypotension
- Swallowing difficulties: Dysphagia
¶ Depression and Anxiety Disorders
- CRH hyperactivity: Elevated CRH in CeA
- SST deficits: Reduced somatostatin
- NPY reduction: Anxiety susceptibility
- Generalized anxiety: CeA hyperactivity
- Panic disorder: CeA fear circuits
- Phobias: Conditioned fear responses
- PTSD: Impaired extinction
- Seizure propagation: CeA as relay
- Fear memories: Affective components
- Autonomic seizures: Ictal symptoms
- Benzodiazepines: GABA-A enhancement
- SSRIs/SNRIs: Serotonin modulation
- CRH antagonists: Stress reduction
- TCAs: Broad neurotransmitter effects
- Ketamine: NMDA modulation
- SSRIs: Plasticity enhancement
- Target: CeA or terminals
- Effects: Anxiety reduction
- Clinical trials: Ongoing
- CRH reduction: Viral vectors
- NPY enhancement: Anxiety treatment
- Optogenetic approaches: Circuit manipulation
- Single-cell sequencing
- Viral tracing
- Optogenetic circuit analysis
- Animal models of neurodegeneration
- Biomarker development
- Therapeutic targets
- Novel anxiolytics
- Neuromodulation approaches
- Cell replacement therapies
The study of Central Nucleus Amygdala Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci. 1992;15:353-375.
-
LeDoux JE. The amygdala. Curr Biol. 2007;17(20):R868-R874.
-
Pare D, Quirk GJ, Ledoux JE. New vistas on amygdala networks and behavior. J Neurosci. 2004;24(46):10364-10368.
-
Gilpin NW, Herman MA, Roberto M. The central amygdala as an integrative hub for anxiety and alcohol use disorders. Biol Psychiatry. 2015;77(10):859-869.
-
Tovote P, Fadok JP, Lüthi A. Neuronal circuits for fear and anxiety. Nat Rev Neurosci. 2015;16(6):317-331.
-
Janak PH, Tye KM. From circuits to behaviour in the amygdala. Nature. 2015;517(7534):284-292.
-
Calhoon GG, Tye KM. Resolving the neural circuits of anxiety. Nat Neurosci. 2015;18(10):1394-1404.
-
Sehlmeyer C, Dannhauer M,三峡 A, et al. Neural correlates of trait anxiety in fear conditioning. Psychiatry Res. 2011;194(3):235-246.
-
Shin LM, Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology. 2010;35(1):169-191.
-
Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007;164(10):1476-1488.